Molecular imaging company Positron has opened a 10,000-square-foot cGMP-ready facility in Indiana for manufacturing both radioactive and non-radioactive pharma products and devices. The contract manufacturer, which specializes in nuclear cardiology, plans to focus initially on small batch, radioactive PET products. Positron release
Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes
Wednesday, March 24 | 2pm ET / 11am PT
Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.
